176 related articles for article (PubMed ID: 17149793)
1. Synthesis and biological evaluation of some pyrrolo[2,3-d]pyrimidines.
Rashad AE; Mohamed MS; Zaki ME; Fatahala SS
Arch Pharm (Weinheim); 2006 Dec; 339(12):664-9. PubMed ID: 17149793
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiviral evaluation of some sugar arylglycinoylhydrazones and their oxadiazoline derivatives.
Abdel-Aal MT; El-Sayed WA; El-Ashry el-SH
Arch Pharm (Weinheim); 2006 Dec; 339(12):656-63. PubMed ID: 17149795
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiviral screening of some thieno[2,3-d]pyrimidine nucleosides.
Rashad AE; Ali MA
Nucleosides Nucleotides Nucleic Acids; 2006; 25(1):17-28. PubMed ID: 16440982
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
Renau TE; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral evaluation of some new pyrazole and fused pyrazolopyrimidine derivatives.
Rashad AE; Hegab MI; Abdel-Megeid RE; Micky JA; Abdel-Megeid FM
Bioorg Med Chem; 2008 Aug; 16(15):7102-6. PubMed ID: 18635363
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of pyrazolo[4',3':5,6]pyrano[2,3-d]pyrimidine derivatives for antiviral evaluation.
Shamroukh AH; Zaki ME; Morsy EM; Abdel-Motti FM; Abdel-Megeid FM
Arch Pharm (Weinheim); 2007 May; 340(5):236-43. PubMed ID: 17464958
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines.
Rashad AE; Hegab MI; Abdel-Megeid RE; Fathalla N; Abdel-Megeid FM
Eur J Med Chem; 2009 Aug; 44(8):3285-92. PubMed ID: 19285757
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiviral evaluation of 5-(1,2,3-triazol-1-ylmethyl)uridine derivatives.
Abdel-Rahman AA; Wada T
Z Naturforsch C J Biosci; 2009; 64(3-4):163-6. PubMed ID: 19526706
[TBL] [Abstract][Full Text] [Related]
9. Anti-HAV activity of some newly synthesized triazolo[4,3-b]pyridazines.
Shamroukh AH; Ali MA
Arch Pharm (Weinheim); 2008 Apr; 341(4):223-30. PubMed ID: 18214848
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antiproliferative, and antiviral activity of certain 4-substituted and 4,5-disubstituted 7-[(1,3-dihydroxy-2-propoxy)methyl]pyrrolo[2,3-d]pyrimidines.
Pudlo JS; Nassiri MR; Kern ER; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1990 Jul; 33(7):1984-92. PubMed ID: 2163454
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activity.
Evers DL; Breitenbach JM; Borysko KZ; Townsend LB; Drach JC
Antimicrob Agents Chemother; 2002 Aug; 46(8):2470-6. PubMed ID: 12121920
[TBL] [Abstract][Full Text] [Related]
12. Novel synthesis of pyrrolo [2,3-d] pyrimidines bearing sulfonamide moieties as potential antitumor and radioprotective agents.
Ismail MM; Ghorab MM; Noaman E; Ammar YA; Heiba HI; Sayed MY
Arzneimittelforschung; 2006; 56(4):301-8. PubMed ID: 16724517
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of anti-HIV-1 and anti-HSV-1 activities of 4H-[1,2,4]-triazolo[1,5-a]pyrimidin-5-one derivatives.
Abdel-Hafez AA; Elsherief HA; Jo M; Kurokawa M; Shiraki K; Kawahata T; Otake T; Nakamura N; Hattori M
Arzneimittelforschung; 2002; 52(11):833-9. PubMed ID: 12489255
[TBL] [Abstract][Full Text] [Related]
14. Pyrido[2, 3-d]pyrimidines and pyrimido[5',4':5, 6]pyrido[2, 3-d]pyrimidines as new antiviral agents: synthesis and biological activity.
Nasr MN; Gineinah MM
Arch Pharm (Weinheim); 2002 Jun; 335(6):289-95. PubMed ID: 12210772
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral activities of some 4,4'-dihydroxytriphenylmethanes.
Mibu N; Yokomizo K; Uyeda M; Sumoto K
Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1325-7. PubMed ID: 14600384
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiviral activity of some acyclic and C-acyclic pyrrolo[2,3-d]pyrimidine nucleoside analogues.
Bennett SM; Nguyen-Ba N; Ogilvie KK
J Med Chem; 1990 Aug; 33(8):2162-73. PubMed ID: 2165163
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines.
Renau TE; Kennedy C; Ptak RG; Breitenbach JM; Drach JC; Townsend LB
J Med Chem; 1996 Aug; 39(18):3470-6. PubMed ID: 8784444
[TBL] [Abstract][Full Text] [Related]
18. N-monocarbamoyl derivatives of symmetrical diamines with antiviral activity.
Mibu N; Yokomizo K; Miyata T; Sumoto K
Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1406-11. PubMed ID: 17827774
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of certain pyrimido[2,1-b]benzothiazole and benzothiazolo[2,3-b]quinazoline derivatives for in vitro antitumor and antiviral activities.
el-Sherbeny MA
Arzneimittelforschung; 2000 Sep; 50(9):848-53. PubMed ID: 11050704
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiviral evaluation of 2'-C-methyl analogues of 5-alkynyl- and 6-alkylfurano- and pyrrolo[2,3-d]pyrimidine ribonucleosides.
Januszczyk P; Fogt J; Boryski J; Izawa K; Onishi T; Neyts J; De Clercq E
Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):713-23. PubMed ID: 20183611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
